<DOC>
	<DOCNO>NCT01441505</DOCNO>
	<brief_summary>Recently , interest emerge use ketamine antidepressant . Recent placebo-controlled clinical trial administer single dose open label trial give repeat dos show ketamine markedly superior placebo reduce depression , include treatment-resistant patient , antidepressant effect rapid onset . This clinical study consist two phase . In Phase I , participant satisfy inclusion criterion receive ketamine variable dos ( 0.1mg/kg-0.5mg/kg ) placebo ( saline , 0.01mg/kg midazolam ) week 6 week . If participant qualify Phase II , receive repeat session ketamine variable dos three week . During phase , mood , psychiatric , neuropsychological outcome measure .</brief_summary>
	<brief_title>A Study Ketamine Antidepressant</brief_title>
	<detailed_description>This clinical study consist two phase . In Phase I , participant receive variable dos intravenous , intramuscular , subcutaneous ketamine ( 0.1-0.5mg/kg ) placebo ( saline , 0.01mg/kg midazolam ) weekly 6 consecutive week . Prior receive ketamine/placebo , participant ' mood psychiatric symptom assess . Once received treatment , mood , psychiatric side effect , ketamine blood level , heart rate , blood pressure biomarkers assess . Mood cognitive performance assess 4 hour . Finally , mood also assess next day . Some participant may eligible continue Phase II . In phase , participant receive dos ketamine approximately weekly 6 month . During phase , participant ' mood , psychiatric , biomarkers cognitive outcome assess . The purpose trial investigate antidepressant safety effect use ketamine treatment depression .</detailed_description>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Satisfy DSMIVTR criterion Major Depressive Episode 18 year Able give inform consent Diagnosis schizophrenia , schizoaffective disorder , rapid cycling bipolar disorder , current psychotic symptom Known sensitivity contraindication ketamine Recent drug abuse Pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>